BIOM UP SA news, videos and press releases
For more news please use our advanced search feature.
BIOM UP SA - More news...
BIOM UP SA - More news...
- DGAP-News: Biom'up announces the approval of HEMOBLAST(TM) Bellows and its laparoscopic applicator in Australia
- DGAP-News: Biom'up: Approval of 2019 H1 interim results postponed: Board of Directors pursues review of options available to the Company
- DGAP-News: Biom'up strengthens management team
- DGAP-News: Biom'up: New Publication Highlights Application of HEMOBLAST(TM) Bellows in Cardiovascular Surgery
- DGAP-News: Biom'up issues a new tranche of EUR 5 million from the credit line granted by Athyrium
- DGAP-News: Biom'up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year
- DGAP-News: Industry Veteran Dr. Jan Ohrstrom takes on Executive Leadership of Biom'up
- DGAP-News: Biom'up to Present at the RBC Capital Markets Global Healthcare Conference on Tuesday May 21, 2019 in New York City
- DGAP-News: Biom'up provides 2019 guidance for HEMOBLAST(TM) Bellows global sales
- DGAP-News: Biom'up reports 2018 full-year results and provides a business update
- DGAP-News: Biom'up granted FDA IDE approval for HEMOSNOW(TM)
- DGAP-News: Biom'up announces first US sales in laparoscopy for HEMOBLAST(TM) Bellows and the signing of an exclusive distribution agreement for HEMOBLAST(TM) Bellows in Australia
- DGAP-News: Biom'up Notice of 2018 Year End results
- DGAP-News: Biom'up appoints George Makhoul as Chief Commercial Officer (USA)
- DGAP-News: Biom'up HEMOBLAST(TM) Bellows full pivotal trial results published in Journal of Cardiac Surgery
- DGAP-News: Biom'up granted FDA approval for its HEMOBLAST(TM) Bellows Laparoscopic Applicator
- DGAP-News: Biom'up raises EUR3 million from the EUR10 million credit line granted in March 2018 by Athyrium
- DGAP-News: Biom'up successfully closes a EUR7.67 million private placement financing
- DGAP-News: Biom'up launches a private placement financing of a minimum of EUR 7 million
- DGAP-News: Biom'up sees a strong commercial uptake in HEMOBLAST(TM) Bellows in the US and Europe
- DGAP-News: Biom'up announces completion of the 2018 scale-up of its manufacturing facility to meet commercial demand for HEMOBLAST(TM) Bellows
